Answers are grounded in this paper and cite their sources.
PURPOSES: To study the epidemiological, clinical, and laboratory aspects of pancreatic pancreatic cancer in Togo, as well as its management. PATIENTS AND METHOD: This retrospective, descriptive study includes patients diagnosed with such cancers over an 8-year period based on features observed on imaging (ultrasound and computed tomography). RESULTS: During the study period, 30 patients, accounting for 0.68% of all admissions, were diagnosed with pancreatic cancer. Their average age was 55.6 years. The M/F sex ratio was 1.72. Weight loss was the most frequent clinical sign, found in 93%. Epigastric pain was reported by 60%. Laboratory results included cholestasis in 97%, hyperglycemia in 47%, hyperlipasemia in 17%, hyperamylasuria in 13%, and hyperamylasemia in 10%. Assays showed elevated Ca19-9 in 23% of patients and elevated ACE in 7%. Abdominal ultrasound showed a poorly defined heterogeneous mass that deformed the contours of the pancreas, with the tumor in the head of the pancreas in 96% of patients. Abdominal CT showed a pancreatic tumor of variable size with hepatic metastases and dilatation of the pancreatic duct in 11 cases. Management involved mainly administration of step 2 or 3 analgesics. The average duration of hospitalization was 12.4 days and death occurred before discharge in 87% of the cases. CONCLUSION: The incidence of pancreatic cancer seems to be rising in Togo. Its prognosis is very poor. Early detection is essential to reduce mortality.
No takes yet. Share an insight, caveat, or question.
Bouglouga et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: